Medical cost-effectiveness analysis (CEA) is perhaps the most widely applied tool to guide policy decisions concerning the use of health care resources. This chapter first reviews the rationale for and common practice of medical cost-effectiveness analysis. It seeks to place CEA within a...

Background: Decision-analytic modelling (DAM) has become a widespread method in health technology assessments (HTA), but the extent to which modelling is used differs among international HTA institutions. In Germany, the use of DAM is optional within HTAs of the German Institute of Medical...

We evaluate the introduction of various forms of antihypertensive treatment in France with a distribution-sensitive cost-benefit analysis. Compared to traditional cost-benefit analysis, we implement distributional weighting based on equivalent incomes, a new concept of individual well-being that...